These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1446358)

  • 41. Studies on the hypotensive mechanisms of NZ-105, a new dihydropyridine derivative, in rats and rabbits.
    Shudo C; Masuda Y; Sakai T; Tanaka S; Shigenobu K; Kasuya Y
    Gen Pharmacol; 1993 Mar; 24(2):411-8. PubMed ID: 8482525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing nitrooxyalkylester moieties at the 3- and 5-positions.
    Ogawa T; Nakazato A; Tsuchida K; Hatayama K
    Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1049-54. PubMed ID: 8370105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and Ca2+ antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H- 1,4-benzothiazines.
    Fujita M; Ito S; Ota A; Kato N; Yamamoto K; Kawashima Y; Yamauchi H; Iwao J
    J Med Chem; 1990 Jul; 33(7):1898-905. PubMed ID: 2362267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
    Inglesi M; Nicola M; Magnetti S
    Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists.
    Jiang J; Li AH; Jang SY; Chang L; Melman N; Moro S; Ji X; Lobkovsky EB; Clardy JC; Jacobson KA
    J Med Chem; 1999 Aug; 42(16):3055-65. PubMed ID: 10447949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative aromatization of Hantzsch 1,4-dihydropyridines in the presence of mixed-addenda vanadomolybdophosphate heteropolyacid, H6PMo9V3O40.
    Heravi MM; Derikvand F; Hassan-Pour S; Bakhtiari K; Bamoharram FF; Oskooie HA
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3305-9. PubMed ID: 17452103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
    Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.
    Rovnyak GC; Atwal KS; Hedberg A; Kimball SD; Moreland S; Gougoutas JZ; O'Reilly BC; Schwartz J; Malley MF
    J Med Chem; 1992 Aug; 35(17):3254-63. PubMed ID: 1387168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A structural study of 4-aminoantipyrine and six of its Schiff base derivatives.
    Mnguni MJ; Lemmerer A
    Acta Crystallogr C Struct Chem; 2015 Feb; 71(Pt 2):103-9. PubMed ID: 25652276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of expected metabolites of benidipine hydrochloride.
    Muto K; Kuroda T; Kawato H; Nishikawa H; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1666-70. PubMed ID: 3219138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 312():86-103. PubMed ID: 1663336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
    Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
    Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hantzsch 1,4-dihydropyridines containing a diazen-1-ium-1,2-diolate nitric oxide donor moiety to study calcium channel antagonist structure-activity relationships and nitric oxide release.
    Nguyen JT; Velázquez CA; Knaus EE
    Bioorg Med Chem; 2005 Mar; 13(5):1725-38. PubMed ID: 15698790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and calcium antagonist activity of 1,4-dihydropyridines containing phenylaminoimidazolyl substituents.
    Zarghi A; Sadeghi H; Fassihi A; Faizi M; Shafiee A
    Farmaco; 2003 Nov; 58(11):1077-81. PubMed ID: 14572858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potentiation of the vincristine effect on P388 mouse leukemia cells by a newly synthesized dihydropyridine analogue, PAK-200.
    Shudo N; Fujii R; Matsumoto T; Mizoguchi T; Seto K; Sakoda R; Akiyama S
    Jpn J Cancer Res; 1992 Sep; 83(9):1011-7. PubMed ID: 1429198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 1st communication: comparative studies on the cardiovascular effects of methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2,3- b]pyridine-5-carboxylate and its two enantiomers in experimental animals.
    Ueda M; Matsumura S; Masui M; Matsuura E; Uno O; Kawakami M; Ninomiya M; Adachi I
    Arzneimittelforschung; 1993 Dec; 43(12):1270-5. PubMed ID: 8141813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.
    Navidpour L; Miri R; Shafiee A
    Arzneimittelforschung; 2004; 54(9):499-504. PubMed ID: 15500195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
    Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
    Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.